Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Dec 7;97(23):e2304-e2314.
doi: 10.1212/WNL.0000000000012910. Epub 2021 Oct 13.

Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis

Affiliations
Meta-Analysis

Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis

Jonathan Broomfield et al. Neurology. .

Abstract

Background and objectives: Duchenne muscular dystrophy (DMD) is a rare progressive disease that is often diagnosed in early childhood and leads to considerably reduced life expectancy; because of its rarity, research literature and patient numbers are limited. To fully characterize the natural history, it is crucial to obtain appropriate estimates of the life expectancy and mortality rates of patients with DMD.

Methods: A systematic review of the published literature on mortality in DMD up to July 2020 was undertaken, specifically focusing on publications in which Kaplan-Meier (KM) survival curves with age as a timescale were presented. These were digitized, and individual patient data (IPD) were reconstructed. The pooled IPD were analyzed with the KM estimator and parametric survival analysis models. Estimates were also stratified by birth cohort.

Results: Of 1,177 articles identified, 14 publications met the inclusion criteria and provided data on 2,283 patients, of whom 1,049 had died. Median life expectancy was 22.0 years (95% confidence interval [CI] 21.2, 22.4). Analyses stratified by 3 time periods in which patients were born showed markedly increased life expectancy in more recent patient populations; patients born after 1990 have a median life expectancy of 28.1 years (95% CI 25.1, 30.3).

Discussion: This article presents a full overview of mortality across the lifetime of a patient with DMD and highlights recent improvements in survival. In the absence of large-scale prospective cohort studies or trials reporting mortality data for patients with DMD, extraction of IPD from the literature provides a viable alternative to estimating life expectancy for this patient population.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow of Identified DMD Mortality Articles on PubMed
DMD = Duchenne muscular dystrophy; IPD = individual patient data; KM = Kaplan-Meier. *The KM curve in 1 article did not use age as a timescale, but the age of patients could be calculated.
Figure 2
Figure 2. Kaplan-Meier Estimates, (A) Pooled and (B) Split by Birth Cohort, From the Digitized Data

Similar articles

Cited by

References

    1. San Martin PP, Solis FF, Cavada CG. Survival of patients with Duchenne muscular dystrophy. Revista Chilena de Pediatria. 2018;89(4):477. - PubMed
    1. Mochizuki H, Miyatake S, Suzuki M, et al. . Mental retardation and lifetime events of Duchenne muscular dystrophy in Japan. Intern Med. 2008;47(13):1207-1210. - PubMed
    1. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord. 2002;12(10):926-929. - PubMed
    1. Wang M, Birnkrant DJ, Super DM, Jacobs IB, Bahler RC. Progressive left ventricular dysfunction and long-term outcomes in patients with Duchenne muscular dystrophy receiving cardiopulmonary therapies. Open Heart. 2018;5(1):e000783. - PMC - PubMed
    1. Bergen JC, Ginjaar HB, Essen AJ, et al. . Forty-five years of Duchenne muscular dystrophy in the Netherlands. J Neuromuscul Dis. 2014;1(1):99-109. - PubMed

Publication types